Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus

Abstract excerpt

BACKGROUND: Staphylococcus aureus is a major human pathogen and strains resistant to existing treatments continue to emerge. Development of novel treatments is therefore important. Antimicrobial peptides represent a source of potential novel antibiotics to combat resistant bacteria such as Methicillin-Resistant Staphylococcus aureus (MRSA). A promising antimicrobial peptide is ranalexin, which has potent activity...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antimicrobial Peptides and Activities
• Share to Antimicrobial Resistance in Staphylococcus
• Share to vaccines and immunoinformatics approaches